zzlangerhans’ Activity

Sat Jul 19

CAPS Underperform Pitch

zzlangerhans wrote about Alexza Pharmaceuticals, Inc. (ALXA) . 1:23 AM

ALXA Underperform

On August 7, we'll get the first concrete information on the launch of Adasuve. Alexza's partner Teva started marketing the drug in the US in March, so the Q2 earnings call should contain a full quarter of revenue. As I've stated previously, I don't [more]

Fri Jul 18

Caps Pick

zzlangerhans made a pick in CAPS. 10:54 AM

Alexza Pharmaceuticals, Inc. (ALXA) will Underperform the S&P 500

Fri Jul 11

CAPS Outperform Pitch Reply

zzlangerhans commented on zzlangerhans's pitch for OCRX. 11:32 AM

Bought 1000 shares today at 5.78. Not real excited about this but seems like upside is larger than downside for now. Will probably dump this if it keeps going south.

Thu Jul 10

CAPS Underperform Pitch Reply

zzlangerhans commented on zzlangerhans's pitch for VNDA. 10:26 AM

Covered at 14.09 today for profit of $1450, still think this company and stock eventually die.

Mon Jul 7

CAPS Outperform Pitch

zzlangerhans wrote about MacroGenics, Inc. (MGNX) . 10:30 PM

MGNX Outperform

MacroGenics seems to be a little more substantial than the other 2013 biopharma IPO's I've recently been catching up on. The company matured their platforms and advanced their pipeline for thirteen years before going public, with the result that the [more]

CAPS Outperform Pitch Reply

zzlangerhans commented on zzlangerhans's pitch for GLYC. 11:53 AM

Sold all 1000 shares at 9.12 for profit of $2320.

Caps Pick

zzlangerhans made a pick in CAPS. 10:57 AM

MacroGenics, Inc. (MGNX) will Outperform the S&P 500

Fri Jul 4

CAPS Outperform Pitch

zzlangerhans wrote about KAMADA ORD ILS1.00 (KMDA) . 9:58 PM

KMDA Outperform

Kamada is kind of a weird company. Aside from being an Israeli biotech, which I've found to be a highly weird niche of the biopharma sector, the company offers a strange mix of marketed products and therapeutics in clinical development.The company's [more]

Thu Jul 3

Caps Pick

zzlangerhans made a pick in CAPS. 11:37 AM

KAMADA ORD ILS1.00 (KMDA) will Outperform the S&P 500

Wed Jul 2

CAPS Underperform Pitch

zzlangerhans wrote about Synageva BioPharma (GEVA) . 11:23 PM

GEVA Underperform

Monday was another one of those days in which my primary income source (my job) worked against my secondary income source (the market). I've been eagerly anticipating the release of topline data from the ARISE phase III trial of sebelipase alfa for [more]

Tue Jul 1

Caps Pick

zzlangerhans made a pick in CAPS. 10:00 AM

Synageva BioPharma (GEVA) will Underperform the S&P 500

Sat Jun 28

CAPS Outperform Pitch

zzlangerhans wrote about ZAFGEN INC COM USD0.001 (ZFGN) . 1:39 PM

ZFGN Outperform

I decided to move Zafgen ahead of about 30 other biopharma IPO's I've neglected to research because of Feuerstein's article last week where he identifies Zafgen and Bluebird as two biopharma companies he actually likes. Portefeuille loves Bluebird [more]

Caps Pick

zzlangerhans made a pick in CAPS. 1:39 PM

ZAFGEN INC COM USD0.001 (ZFGN) will Outperform the S&P 500

Fri Jun 27

CAPS Outperform Pitch Reply

zzlangerhans commented on zzlangerhans's pitch for GLYC. 9:02 AM

Depends on the center of gravity of the sector. Right now there's tons of crap valued in the 300's and 400's. GlycoMimetics is neither crap nor gold pending more data. Mast, on the other hand, is proven crap. Sometimes these unknowns turn into [more]

Thu Jun 26

CAPS Outperform Pitch Reply

zzlangerhans commented on zzlangerhans's pitch for NSPH. 10:46 PM

I reviewed Nanosphere again about a week ago and decided it seemed to have stabilized from the rapid decline and I was setting up to buy below 1.3. That day the stock gapped up on the open so I missed my buy-in, and now I'm just waiting to see what [more]

CAPS Underperform Pitch Reply

zzlangerhans commented on zzlangerhans's pitch for VNDA. 6:40 AM

I am currently short 1000 Vanda with a basis of 15.54.

Wed Jun 25

CAPS Outperform Pitch

zzlangerhans wrote about GlycoMimetics, Inc. (GLYC) . 1:42 PM

GLYC Outperform

As the biopharma sector as resurged from the April lows (neatly marked by my spec capitulation), I've been selling off substantial chunks of core holdings like Flamel and Enanta and eliminating some recovered positions like Achillion. At the same [more]

Tue Jun 24

Caps Pick

zzlangerhans made a pick in CAPS. 3:51 PM

GlycoMimetics, Inc. (GLYC) will Outperform the S&P 500

Sat Jun 21

CAPS Outperform Pitch

zzlangerhans wrote about RXI PHARMACEUTICALS (RXII) . 8:53 PM

RXII Outperform

I lost my old RXi pitch when CAPS admins suddenly decided to retire the original RXII ticker, convert all GALE picks into RXII picks, and create a new GALE ticker. Perhaps this originates from the fact that RXi was spun off by Galena in 2012. Of [more]

Thu Jun 19

CAPS Underperform Pitch Reply

zzlangerhans commented on zzlangerhans's pitch for NWBO. 11:05 AM

Just made another $730 shorting Northwest. Details are on my Twitter stream. I may start putting this trade in my regular rotation.

Show More Activity ...

CAPS Stats & Trivia

CAPS Player Rating 99.70
Player Rank 224 out of 75008
Score 5074.31
Score Change Today +34.97
Accuracy 82.03%
Active Picks 167
Total Picks 1928
Best Pick BDSI (+1070.42)
Worst Pick PCYC (-2886.09)
Average Score per Pick 2.63
Charms Earned 15
Highest Rated Favorite vanamonde
Go to zzlangerhans’ CAPS page

Boards Stats & Trivia

Board Posts 0
Recs Received 0
People who have rec'd these posts 0
Recs to Posts Ratio (last 30 days) N/A
Threads Started 0
Threads Started Percentage 0.00 %
Most Frequent Board N/A
Very First Post N/A
Percentage of Posts Rec'd 100.00 %
Show zzlangerhans’ 10 Latest Posts